title: Immunohistochemical evaluation of the marbled state in childhood hypoxic encephalopathy.
abstract: We have immunohistochemically analyzed the marbled state in 8 cases of perinatal hypoxic ischemic encephalopathy and 4 cases of infantile hypoxic encephalopathy, using antibodies against calbindin-D28k (CaBD), glial fibrillary acidic protein (GFAP), methionine-enkephalin (MEnk), myelin basic protein (MBP), neurofilament (NF), parvalbumin (PV), substance-P (SuP) and synaptophysin (SP). The marbled state was found in the thalamus in 11 cases, whose age at death was over 10 years. Four cases demonstrated the marbled state in the cerebral cortex, in addition to the striatum and/or the thalamus. The abnormally myelinated fibers in the marbled state were stained with both Kluver-Barrera and Holzer stainings; however, they were partly immunopositive for MBP and completely immunonegative for GFAP, CaBD, MEnk, PV, SuP and SP, although some of the neurons and/or fibers showed immunoreactivities for those calcium-binding proteins and/or neurotransmitters. The axons were visualized in the abnormally myelinated fibers by Bodian staining and/or anti-NF immunostainings in the cerebral cortex and striatum but not in the thalamus. GFAP-positive astrocytes did not show any continuity with the abnormally myelinated fibers. These histological features were seen in the cerebral cortex, striatum and thalamus. Difference of the etiology did not affect the histological features with the exception of anti-PV staining, in which PV-immunopositive neurons were observed only in aged subjects with infantile hypoxic encephalopathy, and seemed to be more severely affected by hypoxic stress during the perinatal period than the early infantile period. These data suggest that the site of lesion or the length of survival period after brain injury might influence the formation of the marbled state rather than the etiology. And the direct relationship between the abnormally myelinated fiber and astrocytic process was not verified.
authors.affiliation: Department of Clinical Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Fuchu-shi, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Araki
authors.forename: M
authors.initials: M
authors.lastname: Hayashi
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: J
authors.initials: J
authors.lastname: Nagata
authors.forename: K
authors.initials: K
authors.lastname: Kurata
authors.forename: Y
authors.initials: Y
authors.lastname: Morimatsu
authors.forename: H
authors.initials: H
authors.lastname: Matsuyama
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000906:Antibodies; D001238:Asphyxia Neonatorum / Q000473:pathology*; D064092:Calbindin 1; D064026:Calbindins; D002540:Cerebral Cortex / Q000737:chemistry / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005911:Gliosis / Q000473:pathology; D006801:Humans; D002534:Hypoxia, Brain / Q000473:pathology*; D007124:Immunoenzyme Techniques; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D017072:Neostriatum / Q000473:pathology*; D009413:Nerve Fibers, Myelinated / Q000737:chemistry / Q000473:pathology; D010320:Parvalbumins / Q000032:analysis / Q000276:immunology; D064030:S100 Calcium Binding Protein G / Q000032:analysis / Q000276:immunology; D013788:Thalamus / Q000737:chemistry / Q000473:pathology*
chemical_list: D000906:Antibodies; C576498:CALB1 protein, human; D064092:Calbindin 1; D064026:Calbindins; D010320:Parvalbumins; D064030:S100 Calcium Binding Protein G